Bacterial Hospital Acquired Infection in Port Sudan Teaching Hospital, Red Sea State, Sudan
International Journal of Pharmacy and Chemistry
Volume 4, Issue 1, January 2018, Pages: 1-7
Received: Dec. 2, 2017;
Accepted: Dec. 25, 2017;
Published: Jan. 15, 2018
Views 2353 Downloads 219
Abd Elrahman Mustafa Abd Elrahman Osman, Medical Laboratory Sciences Division, Port Sudan Ahlia College, Port Sudan, Sudan
Shingray Osman Hashim, Medical Laboratory Sciences Division, Port Sudan Ahlia College, Port Sudan, Sudan
Mohammed Abdall Musa, Medical Laboratory Sciences Division, Port Sudan Ahlia College, Port Sudan, Sudan
Omer Mohammed Tahir, Medical Laboratory Sciences Division, Port Sudan Ahlia College, Port Sudan, Sudan
Follow on us
This study was carried out in Port Sudan teaching hospital from 8 November 2011 work to be initiated by the determination of level of aerobic bacterial contamination in the hospitals in port Sudan to 8November 2013. The aim of this study to isolate and identify different types of aerobic bacterial Hospital Acquired Infection, and determination of levels of antibiotic resistance of aerobic nosocomial isolate to commonly used antimicrobial agents. Two hundred samples collected from Urinary tract, Wound, Sputum, Ear, Throat, Blood, Personnel and different site of ward. The result showed that the isolated microorganism were as followed: Escherichia coli 33 (16.5%), S. aureus 21 (10.5%), Pseudomonas aeruginosa 20 (10%), Klebsiella pneumonia 17 (8.5%), Strepto Pyogene 9 (4.5%), Strepto faecalis 7 (3.5%), proteus mirabilis 4 (2%), proteus vulgaris 4 (2%), Morganella Morgenii 2 (1%), Klebsiella oxytoca 2 (1%), S. epidermidis 2 (1%), Salmonella Para A 1 (0.5) Citrbacter Ferundii 1 (0.5%), Serratia Spp 1 (0.5%). Also the result showed that the majority of bacterial strains tested, exhibited marked most multiple drug resistance against some broad -spectrum antimicrobials used eg: Ceftazidime, it was evident that of the Gentamicin, Ciprofloxacin, Cefixime and Ceftriaxone is choice drug for Hospital Acquired Infection. This study concluded the effective control, prevention and treatment of infection. Knowledge of emerging pathogens and resistance profile is essential for treatment against Hospital Acquired infections.
Hospital Acquired Infection, Urinary Tract Infections, Escherichia Coli, Port Sudan
To cite this article
Abd Elrahman Mustafa Abd Elrahman Osman,
Shingray Osman Hashim,
Mohammed Abdall Musa,
Omer Mohammed Tahir,
Bacterial Hospital Acquired Infection in Port Sudan Teaching Hospital, Red Sea State, Sudan, International Journal of Pharmacy and Chemistry.
Vol. 4, No. 1,
2018, pp. 1-7.
Copyright © 2018 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/
) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Evans, A. E; and Feldmen, H. A., (1982). In: Bacterial Infection of Humans, Epidemology and Control. A. S Evans and H. A. Feldman (eds), Plenum Pub. Co., New York, pp. 367-368 and 371-372.
Toledo-Pereyra, LH.; and Toledo, M. M., (1976). A critical study of Lister’s work onantiseptic surgery. A m J. Surg., 131: 736-744.
Spicer. W. J, clinical Bacteriology, Mycology and Parasitology. CHURCHILL LIVING STONE: 2000: Page 190-192.
Greenwood, Slack. Richard. C. B and Pentherer, John. F. (2002). Medical publishers Microbiology, A guide to microbial infection, sixteen edition, P. 250-275. Churchill living stone.
Gupta K. Emerging antibiotic resistance in urinary tract pathogens Infect Dis Clin North Am. 2003; 17 (2): 243-59.
Mims Cedric, dock ell. Hazel. M, Goering. V, Riot. Ivan, Wakelin. Derek and. Zuckerman. Mark. (2004). Medical Microbiology, third edition, ELSEVIER MOSBY.
Haussen Karen. (2005). Infection Control Staff Fact Sheet, Infection control Unit, Women's and Children's Hospital, Children, Youth and Women's Health Service, Government of South Australia.
Hooton TM. Clinical practice. Uncomplicated urinary tract infection. N Engl J Med 2012; 366 (11): 1028-1037.
Jawetz, Mel nick and Adel berg (2007). Medical Microbiology 24th edition, McGraw-Hill companies.
Movahedian AH, Mosayebi Z, Moniri R. Urinary Tract Infections in Hospitalized Newborns in Beheshti Hospital, Iran: A Retrospective Study. J Infect Dis Antimicrob Agents. 2007; 24 (1): 7-11.
EL-MISHAD ABLAM. Manual of Practical Microbiology. Eighth Edition. Cairo: Kalyoub-Egypt, 2006: 149-157.
Janković S, Mirović V, Marković-Denić L, Romić P, Mikić D: Nosocomial bloodstream infections in ICU and non-ICU patients. Am J Infect Control 2005, 33: 333-40.
Daschner F, Chiarello LA, Dettenkofer M, Fabry J, Francioli P, Knopf H-J, et al. Hygiene and infection control of nosocomial catheter-associated urinary tract infection. In: Naber KG, Pechere JC, Kumazawa J, et al., editors. Nosocomial and health care associated infections in urology. London: Health Publication Ltd; 2001. pp. 105-119.
Janković S, Mirović V, Marković-Denić L, Romić P, Mikić D: Nosocomial bloodstream infections in ICU and non-ICU patients.
Orret and Shurland, 1998. Bacterial etiologic agents of urinry tract infection in Hospitalized patients Nigeria, Abuja.
Torkaman M, Afsharpaiman SH, Hoseini MJ, Moradi M, Mazraati A, Amirsalari S, et al. Platelet count and neonatal sepsis: a high prevalence of Enterobacter spp. Singapore Med J. 2009; 50 (5): 482-5.
Eriksen HM, Iversen BG, Aavitsland P. Prevalence of nosocomial infections in hospitals in Norway, 2002 and 2003. J Hosp Infect. 2005; 60: 40–5.
Sharifian M, Karimi A, Tabatabaei SR, Anvaripour N. Microbial sensitivity pattern in urinary tract infections in children: a single center experience of 1,177 urine cultures. Jpn J Infect Dis. 2006; 59 (6): 380-2.
Pitout. Johann. D. D, Nordmann, Laupland. Kevin. B and Poirel. (2005). Emergence of Enterobactericeae Producing Extended Spectrum B-lactamase (ESBLs) in community, Journal of Antibacterial Chemotherapy, 56 (1): 52-59.
Wang JT, Chang SC, Chen YC, Luh KT. “Comparison of antimicrobial susceptibility of Citrobacter freundii isolates in two different time periods.” The Journal of Microbiology, Immunology and Infection. 2000 Dec; 33 (4): 258-62.